Clinical Trials Directory

Trials / Unknown

UnknownNCT00710450

Effect of Montelukast on Basophils, In-vitro

The Effect of Montelukast In-vitro on Basophil Histamine and Leukotriene, IL-4 Adn IL-13 Release in Subjects With Allergic Rhinitis or Allergic Asthma

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Creighton University · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

Subjects with either allergic asthma or allergic rhinitis will be recruited to obtain blood. This blood will be used to be stimulated with to whatever the patient allergic. In the laboratory, this stimulated blood will be measured for histamine, leukotrienes, IL-13 and IL-3. These are chemicals responsible for allergy symptoms.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2008-07-04
Last updated
2011-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00710450. Inclusion in this directory is not an endorsement.

Effect of Montelukast on Basophils, In-vitro (NCT00710450) · Clinical Trials Directory